DTaP Vaccine Market Trend, Growth, Size, Forecast, Key Players and Competitive Landscape Research Report 2028

Growing demand for DTaP vaccines to prevent the occurrence of diseases such as diphtheria, tetanus, and pertussis is a significant factor expected to stimulate market growth.

 

The global DTaP Vaccine market is expected to reach USD 5.51 Billion by 2028, according to a new report by Reports and Data. DTaP (Diphtheria, Tetanus and acellular Pertussis) is an immunization product targeting diphtheria, tetanus, and pertussis, and is usually first given at two months of age. The capital letters "D" and "P" in DTaP relate to increased diphtheria and pertussis antigen concentrations, in comparison to Tdap products.

Factors such as high birth rate and the growing popularity of pertussis vaccination, are anticipated to propel the pertussis vaccine market which in turn would have a positive impact on the DTaP vaccine market globally. According to a survey by WHO in 2015, 126 countries had achieved a minimum 90% coverage of the vaccine. Besides, injuries caused by these vaccines is likely to impede the growth of the global market. In the U.S. in 2015, there had been seven claims registered in the federal VICP (Vaccine Injury Compensation Program) on account of post-pertussis vaccination injuries and deaths, comprising three deaths and four serious injuries.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1284

There is a growing demand for vaccines to prevent the occurrence of diseases such as diphtheria, tetanus and pertussis. These factors are projected to boost the market demand for this vaccine combination in the forecast period. Since 2012, UNICEF has obtained small quantities of DTaP vaccine for Armenia, procuring a supply from a single manufacturer. Nevertheless, since 2014, several countries, particularly MICs that usually self-procure, have expressed interest in obtaining aP-containing combination vaccines for their immunization programs through UNICEF, due to apparent difficulties in getting sufficient DTaP-containing combination vaccine supplies through their regular procurement channels.

Various initiatives being taken by governments across the globe to promote the awareness of vaccination benefits through immunization programs is projected to propel the growth of the market in the upcoming years. 

Further key findings from the report suggest

  • By disease type, the use of the vaccine in treating Pertussis is anticipated to witness a significant growth rate of 7.0% during the forecast period as childhood vaccination is one of the safest and cost-effective ways for the pertussis-free environment.
  • Kinrix is forecasted to hold a significant share of the market with a growth rate of 6.9% during the forecast period.
  • North America contributes to the largest market share in 2020. In the U.S., coverage with DTaP vaccines differ across age groups. Vaccination coverage for children aged 19 to 35 months of age remains consistently high, at 95.0% for ≥3 DTaP dosages and 84.6% for ≥4 DTaP dosages reported in 2015. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S.
  • The Europe and Asia Pacific markets follow the North America market in terms of market dominance.
  • Key participants include GlaxoSmithKline, Sanofi Pasteur, Protein Sciences Corporation, Novartis AG, Merch Sharp & Dohme Corp., Pfizer Inc., Astellas Pharma US, Sanofi Aventis, AstraZeneca, and Emergent Biosolution Inc. among others.

Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/dtap-vaccine-market

For the purpose of this report, Reports and Data have segmented global DTaP Vaccine market on the basis of disease type, product type, end-user, and region:

Disease Type Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028)

  • Diphtheria
  • Tetanus
  • Pertussis

Product Type Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028)

  • Daptacel
  • Infanrix
  • Kinrix
  • Pediarix
  • Pentacel
  • Quaracel

End-user Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028)

  • Hospitals
  • Clinics
  • Vaccination Centers

Buy Premium Research Report @ https://www.reportsanddata.com/report-pricing/1284

Regional Outlook (Volume, Kilo Tons; 2020-2028 and Revenue, USD Million; 2020-2028)

  • North America
    1. U.S.
  • Europe
    1. UK
    2. France
  • Asia Pacific
    1. China
    2. India
    3. Japan
  • Latin America
    1. Brazil
  • MEA

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1284

Explore Latest Trending Research Reports By Reports and Data's

Homeopathy Product Market by Product Type (Tablets, Ointments, Biochemics, Tincture, Dilutions, Others), By Applications (Dermatology, Gastroenterology, Immunology, Neurology, Respiratory, Analgesic & Antipyretic, Others), By Source (Minerals, Animals, Plants), By End-use (Research Laboratories, E-retailers, Retailers, Hospitals, Homeopathic Clinics, Others), and By Region Forecast To 2028

Tuberculosis Testing Market Size, Share And Industry Analysis By Product Type (Culture Based Tests, Nucleic Acid Testing, Mantoux Test (Tuberculin Skin Test), Radiography (Chest X-Ray), Drug Susceptibility Testing (DST), and Others), By Disease Type (Latent and Active), By End-Use, and By Region Forecast to 2028

Generic Injectables Market By Product Type (Large-molecule Injectables, Small-molecule Injectables), By Container Type (Vials, Premixes, Prefilled Syringes, Ampoules, Others), By Application (Infectious Diseases, Anesthesia, Oncology, Cardiology, Immunology, Diabetes, Parenteral Nutrition, Others), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, Others), By Distribution Channel, and By Region, Forecast to 2028

Soft Tissue Sarcoma Treatment Market By Treatment (Chemotherapy, Targeted Therapy, Anti-angiogenesis Drugs, Radiation Therapy, Surgery), By End-use (Hospitals, Oncology Centers, Long Term Care Centers), and By Region Forecast To 2028

About Reports and Data


Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-dtap-vaccine-market

 

Back to news